Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_assertion type Assertion NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_head.
- NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_assertion description "[However, in 2 patients with AML treated with interleukin-3 and granulocyte-colony stimulating factor, respectively, a significant down-regulation of MDR1 expression was found after 24 hours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_provenance.
- NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_assertion evidence source_evidence_literature NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_provenance.
- NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_assertion SIO_000772 7540457 NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_provenance.
- NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_assertion wasDerivedFrom befree-2016 NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_provenance.
- NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_assertion wasGeneratedBy ECO_0000203 NP1311558.RAlyiyHX2WIRYRkAnONFZTTKMRfPZA1QxM3iVh16f3__Q130_provenance.